We are live on ! Find out more
LBPSW

4D Pharma PLC Warrant
LBPSW

Delisted

LBPSW was delisted on the 29th of June, 2022.

5 hedge funds and large institutions have $2.81M invested in 4D Pharma PLC Warrant in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

794% more capital invested

Capital invested by funds: $315K → $2.81M (+$2.5M)

17% less funds holding

Funds holding: 65 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

LBPSW Hedge Fund Activity: Q4 2021 in Review

5 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q4 2021, worth a combined $2.81M — up 794% from $315K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of LBPSW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was UBS Group, opening a new position worth an estimated $915. The largest seller was AQR Arbitrage, cutting an estimated $28.9K.

  • 5 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q4 2021, down from 6 in Q3 2021.
  • Funds reported $2.81M of 4D Pharma PLC Warrant stock for Q4 2021, up 794% quarter-over-quarter.
  • 1 fund opened new 4D Pharma PLC Warrant positions in Q4 2021 and 2 closed out, a net change of -1 holder.
  • The largest 4D Pharma PLC Warrant buyer in Q4 2021 was UBS Group, an estimated $915 added.
  • The largest 4D Pharma PLC Warrant seller in Q4 2021 was AQR Arbitrage, an estimated $28.9K sold.

Based on aggregated 13F filings for Q4 2021.